Sloat Tyler 4
4 · Hinge Health, Inc. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Hinge Health Director Tyler Sloat Receives Award
What Happened
Tyler Sloat, a director of Hinge Health, Inc. (HNGE), was granted 9,896 restricted stock units (RSUs) on March 16, 2026. The Form 4 reports the acquisition as 9,896 shares at $0.00 (award/grant), meaning no cash changed hands at grant.
Key Details
- Transaction date: 2026-03-16; Form 4 filed: 2026-03-18 (two days after the transaction date as reported).
- Transaction type/code: Award/Grant (A).
- Shares/units granted: 9,896 RSUs; reported acquisition price: $0.00; reported dollar value: $0.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote: These are restricted stock units that vest according to the award terms; each RSU represents a contingent right to receive one share of Class A common stock (per Footnote F1).
- No 10b5-1 plan, tax withholding, sale, or exercise activity is noted in this transaction.
Context
RSUs are a form of compensation that convert to actual shares only when they vest per the award schedule; they are not an immediate purchase or sale and do not necessarily indicate near-term buying or selling. This grant increases Sloat’s potential future ownership if and when the RSUs vest, but does not change outstanding shares until settlement.
Insider Transaction Report
Form 4
Sloat Tyler
Director
Transactions
- Award
Class A Common Stock
[F1]2026-03-16+9,896→ 9,896 total
Footnotes (1)
- [F1]Includes 9,896 restricted stock units that vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock.
Signature
/s/ James Budge, Attorney-in-Fact|2026-03-18